TBH Global Asset Management LLC Purchases 479 Shares of HCA Healthcare, Inc. (NYSE:HCA)

TBH Global Asset Management LLC grew its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 8.9% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 5,838 shares of the company’s stock after purchasing an additional 479 shares during the quarter. TBH Global Asset Management LLC’s holdings in HCA Healthcare were worth $1,947,000 as of its most recent filing with the SEC.

Other hedge funds have also recently added to or reduced their stakes in the company. New Mexico Educational Retirement Board lifted its stake in shares of HCA Healthcare by 29.9% in the first quarter. New Mexico Educational Retirement Board now owns 13,900 shares of the company’s stock valued at $4,636,000 after buying an additional 3,200 shares during the period. Apexium Financial LP bought a new position in HCA Healthcare in the fourth quarter worth $361,000. Sanders Capital LLC raised its stake in shares of HCA Healthcare by 4.2% in the 4th quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock valued at $3,086,836,000 after buying an additional 456,738 shares in the last quarter. Todd Asset Management LLC increased its stake in HCA Healthcare by 17.2% in the fourth quarter. Todd Asset Management LLC now owns 226,563 shares of the company’s stock valued at $61,326,000 after acquiring an additional 33,271 shares during the period. Finally, KBC Group NV lifted its stake in HCA Healthcare by 60.6% during the fourth quarter. KBC Group NV now owns 365,984 shares of the company’s stock worth $99,065,000 after purchasing an additional 138,146 shares during the period. Institutional investors own 62.73% of the company’s stock.

Insider Transactions at HCA Healthcare

In related news, SVP Kathryn A. Torres sold 973 shares of the firm’s stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $312.00, for a total value of $303,576.00. Following the completion of the transaction, the senior vice president now owns 22,365 shares of the company’s stock, valued at $6,977,880. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other HCA Healthcare news, SVP Kathryn A. Torres sold 973 shares of the firm’s stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $312.00, for a total value of $303,576.00. Following the completion of the transaction, the senior vice president now directly owns 22,365 shares in the company, valued at $6,977,880. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Michael S. Cuffe sold 1,600 shares of the stock in a transaction that occurred on Monday, May 6th. The shares were sold at an average price of $309.00, for a total value of $494,400.00. Following the completion of the sale, the executive vice president now directly owns 34,124 shares of the company’s stock, valued at approximately $10,544,316. The disclosure for this sale can be found here. Insiders sold 12,397 shares of company stock valued at $3,921,929 in the last ninety days. 1.60% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of research firms have recently issued reports on HCA. StockNews.com upgraded shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Monday, July 1st. Robert W. Baird assumed coverage on HCA Healthcare in a research note on Thursday, May 30th. They issued an “outperform” rating and a $396.00 target price for the company. Barclays increased their price objective on shares of HCA Healthcare from $367.00 to $376.00 and gave the stock an “overweight” rating in a report on Wednesday, July 10th. Wells Fargo & Company increased their price target on shares of HCA Healthcare from $303.00 to $315.00 and gave the company an “equal weight” rating in a research note on Thursday, March 28th. Finally, Oppenheimer increased their price objective on HCA Healthcare from $330.00 to $345.00 and gave the company an “outperform” rating in a research report on Monday, April 29th. Four equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $327.06.

HCA Healthcare Trading Down 0.4 %

Shares of HCA traded down $1.25 during trading hours on Thursday, reaching $321.73. The stock had a trading volume of 1,534,454 shares, compared to its average volume of 1,131,005. HCA Healthcare, Inc. has a 52 week low of $215.96 and a 52 week high of $344.20. The company has a quick ratio of 1.02, a current ratio of 1.16 and a debt-to-equity ratio of 29.26. The company has a market cap of $84.26 billion, a P/E ratio of 16.25, a P/E/G ratio of 1.44 and a beta of 1.68. The firm has a 50-day moving average of $328.09 and a 200 day moving average of $320.91.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, April 26th. The company reported $5.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.01 by $0.35. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. The business had revenue of $17.34 billion during the quarter, compared to analysts’ expectations of $16.81 billion. During the same period in the prior year, the business earned $4.93 EPS. HCA Healthcare’s revenue for the quarter was up 11.2% compared to the same quarter last year. On average, sell-side analysts expect that HCA Healthcare, Inc. will post 20.97 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, June 28th. Investors of record on Friday, June 14th were given a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 0.82%. The ex-dividend date was Friday, June 14th. HCA Healthcare’s dividend payout ratio is presently 13.16%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.